2019 Guide to Medications for the Treatment of Diabetes Mellitus (ePub)
(Sprache: Englisch)
Medications for the Treatment of Diabetes offers a bridge between drug handbooks and pharmacology texts. Focusing entirely on diabetes drugs, this reference is divided into two sections: 1) Drugs used to manage hyperglycemia and 2) Management of diabetic...
sofort als Download lieferbar
eBook (ePub)
68.99 €
34 DeutschlandCard Punkte sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „2019 Guide to Medications for the Treatment of Diabetes Mellitus (ePub)“
Medications for the Treatment of Diabetes offers a bridge between drug handbooks and pharmacology texts. Focusing entirely on diabetes drugs, this reference is divided into two sections: 1) Drugs used to manage hyperglycemia and 2) Management of diabetic co-morbidities.
The first section includes:
-- Pharmacologic Therapy for Type 1 Diabetes
-- Management of Hyperglycemia in Type 1 DM- info from practical use of insulin, pathophysiology, treatment strategy
-- Insulins- RAIAs, Short-acting insulins, intermediate-acting insulins, LAIAs, Concentrated Insulins, Insulin pumps and patches, inhaled insulins, mixed and mixing insulin, use in Type 1, use in Type 2
-- Pharmacologic Therapy for Type 2 Diabetes
-- Management of Hyperglycemia in Type 2- brief overview, pathophysiology, treatment strategy, overview of medications
-- Biguanides
-- TZDs
-- SUs
-- Glinides
-- SGLT-2 Inhibitors
-- AGIs
-- DPP-IV inhibitors
-- GLP RAs
-- Amylin mimetics
-- BARs
-- DA-2 agonists
Each chapter in Section 1 includes:
1. Drug class overview and role in diabetes treatment
2. Pharmacology -- a. Mechanism of action, b. Pharmacokinetics
3. Treatment Advantages/Disadvantages -- a. General for the class, b. When applicable, a discussion of evidence that supports the benefits of using a particular drug in a class over another in the same class (eg, Avandia vs Actos)
4. Therapeutic Considerations -- a. Significant Warnings/Precautions, b. Special Populations, c. Pharmacogenomics, d. Adverse effects and monitoring, e. Drug Interactions, f. Dosage and administration
5. Table with Doses and Dose Adjustments
6. List of important combination products
7. References
The second section includes:
-- Cardiovascular Disease and Risk Management
-- Microvascular Complications and Foot Care
-- Medications for the Management of Hypertension
-- Medications for the Management of Hyperlipidemia
-- Antiplatelet Therapy
-- Medications for Smoking Cessation
-- Medications for the Management of Neuropathy (peripheral and autonomic)
-- Medications for the Management of Nephropathy
-- Medications for the Management of Retinopathy
-- Medications for the Management of Depression
-- Medications for the Management of Hypoglycemia
-- Medications for the Management of Obesity
-- Immunizations in Patients with Diabetes
Each chapter in Section 2 includes:
1. An overview of the condition or problem
2. Goals of treatment
3. Overview of the medications and rationale for the medications used for the problem
4. Overview of each class of medication
5. Overview of combination therapy -- a. first combination, b. second combination
6. Doses and Dose Adjustments for the more salient medications
7. List of important combination products
8. References
The first section includes:
-- Pharmacologic Therapy for Type 1 Diabetes
-- Management of Hyperglycemia in Type 1 DM- info from practical use of insulin, pathophysiology, treatment strategy
-- Insulins- RAIAs, Short-acting insulins, intermediate-acting insulins, LAIAs, Concentrated Insulins, Insulin pumps and patches, inhaled insulins, mixed and mixing insulin, use in Type 1, use in Type 2
-- Pharmacologic Therapy for Type 2 Diabetes
-- Management of Hyperglycemia in Type 2- brief overview, pathophysiology, treatment strategy, overview of medications
-- Biguanides
-- TZDs
-- SUs
-- Glinides
-- SGLT-2 Inhibitors
-- AGIs
-- DPP-IV inhibitors
-- GLP RAs
-- Amylin mimetics
-- BARs
-- DA-2 agonists
Each chapter in Section 1 includes:
1. Drug class overview and role in diabetes treatment
2. Pharmacology -- a. Mechanism of action, b. Pharmacokinetics
3. Treatment Advantages/Disadvantages -- a. General for the class, b. When applicable, a discussion of evidence that supports the benefits of using a particular drug in a class over another in the same class (eg, Avandia vs Actos)
4. Therapeutic Considerations -- a. Significant Warnings/Precautions, b. Special Populations, c. Pharmacogenomics, d. Adverse effects and monitoring, e. Drug Interactions, f. Dosage and administration
5. Table with Doses and Dose Adjustments
6. List of important combination products
7. References
The second section includes:
-- Cardiovascular Disease and Risk Management
-- Microvascular Complications and Foot Care
-- Medications for the Management of Hypertension
-- Medications for the Management of Hyperlipidemia
-- Antiplatelet Therapy
-- Medications for Smoking Cessation
-- Medications for the Management of Neuropathy (peripheral and autonomic)
-- Medications for the Management of Nephropathy
-- Medications for the Management of Retinopathy
-- Medications for the Management of Depression
-- Medications for the Management of Hypoglycemia
-- Medications for the Management of Obesity
-- Immunizations in Patients with Diabetes
Each chapter in Section 2 includes:
1. An overview of the condition or problem
2. Goals of treatment
3. Overview of the medications and rationale for the medications used for the problem
4. Overview of each class of medication
5. Overview of combination therapy -- a. first combination, b. second combination
6. Doses and Dose Adjustments for the more salient medications
7. List of important combination products
8. References
Autoren-Porträt
Volume Editor, John R. White Jr., is chair of the Department of Pharmacotherapy at the Washington State University College of Pharmacy. White is a licensed pharmacist and has a Doctor of Pharmacy (Pharm.D.) degree from Mercer University in Atlanta, GA, and completed a residency and a fellowship in pharmacokinetics/pharmacodynamics at the University of California, San Francisco. He has been affiliated with the WSU College of Pharmacy for more than 20 years. Extensively involved in diabetes research and education since 1987. He is a sought after lecturer on pharmocological research for the treatment of diabetes. In 1998 while a pharmacy professor at WSU, Dr. White completed the University of Washington's physician assistant training.
Bibliographische Angaben
- Altersempfehlung: 22 - 80 Jahre
- 2019, Englisch
- Herausgegeben: John White
- Verlag: American Diabetes Association
- ISBN-10: 158040734X
- ISBN-13: 9781580407342
- Erscheinungsdatum: 06.08.2019
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: ePub
- Größe: 2.49 MB
- Mit Kopierschutz
Sprache:
Englisch
Kopierschutz
Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.
Kommentar zu "2019 Guide to Medications for the Treatment of Diabetes Mellitus"
0 Gebrauchte Artikel zu „2019 Guide to Medications for the Treatment of Diabetes Mellitus“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "2019 Guide to Medications for the Treatment of Diabetes Mellitus".
Kommentar verfassen